73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Repurposing heart drugs to target cancer cells

Repurposing heart drugs to target cancer cells

by MRC London Institute of Medical SciencesCredit: CC0 Public DomainSenescence is a cellular stress response that results in the stable growth arrest of old and damaged cells. The past decade has reve

Repurposing heart drugs to target cancer cells

by MRC London Institute of Medical SciencesCredit: CC0 Public DomainSenescence is a cellular stress response that results in the stable growth arrest of old and damaged cells. The past decade has reve
Erectile dysfunction drugs and flu vaccine may work together to help immune system fight cancer after surgery

Erectile dysfunction drugs and flu vaccine may work together to help immune system fight cancer after surgery

by The Ottawa HospitalNew research shows that erectile dysfunction drugs and flu vaccine may work together to help the immune system fight cancer after surgery. Credit: The Ottawa HospitalA new study

Erectile dysfunction drugs and flu vaccine may work together to help immune system fight cancer after surgery

by The Ottawa HospitalNew research shows that erectile dysfunction drugs and flu vaccine may work together to help the immune system fight cancer after surgery. Credit: The Ottawa HospitalA new study
Direct-to-consumer cancer testing could be beneficial, expert says, but it's not a substitute

Direct-to-consumer cancer testing could be beneficial, expert says, but it's not a substitute

by Leha Byrd,Virginia Commonwealth UniversityWhile the availability of direct-to-consumer genetic testing could be helpful, it also should not dissuade people from seeking professional advice re

Direct-to-consumer cancer testing could be beneficial, expert says, but it's not a substitute

by Leha Byrd,Virginia Commonwealth UniversityWhile the availability of direct-to-consumer genetic testing could be helpful, it also should not dissuade people from seeking professional advice re
The protein behind immunotherapy resistance

The protein behind immunotherapy resistance

byEcole Polytechnique Federale de LausanneTumor with FMRP-deficient cancer cells (in green) being infiltrated and attached by killer (CD8) T cells. Credit: Jeremy Guillot (Hanahan Lab – EPFL).Im

The protein behind immunotherapy resistance

byEcole Polytechnique Federale de LausanneTumor with FMRP-deficient cancer cells (in green) being infiltrated and attached by killer (CD8) T cells. Credit: Jeremy Guillot (Hanahan Lab – EPFL).Im
Smart phone application to increase safety in liver surgery

Smart phone application to increase safety in liver surgery

by Medical University of ViennaCredit: Pixabay/CC0 Public DomainSurgical removal of parts of the liver remains the only curative approach for patients with liver-specific cancer. An international

Smart phone application to increase safety in liver surgery

by Medical University of ViennaCredit: Pixabay/CC0 Public DomainSurgical removal of parts of the liver remains the only curative approach for patients with liver-specific cancer. An international
Daiichi Sankyo soars on $22bn Merck cancer drugs deal

Daiichi Sankyo soars on $22bn Merck cancer drugs deal

Credit: Pixabay/CC0 Public DomainShares in Japan's Daiichi Sankyo soared on Friday after the pharma group announced a major cancer drug deal with US giant Merck worth up to $22 billion.Merck will

Daiichi Sankyo soars on $22bn Merck cancer drugs deal

Credit: Pixabay/CC0 Public DomainShares in Japan's Daiichi Sankyo soared on Friday after the pharma group announced a major cancer drug deal with US giant Merck worth up to $22 billion.Merck will
Drug yields high response rates for lung cancer patients with harsh mutation

Drug yields high response rates for lung cancer patients with harsh mutation

by University of Texas M. D. Anderson Cancer CenterCredit: University of Texas M. D. Anderson Cancer CenterA targeted therapy resurrected by the Moon Shots Program at The University of Texas MD A

Drug yields high response rates for lung cancer patients with harsh mutation

by University of Texas M. D. Anderson Cancer CenterCredit: University of Texas M. D. Anderson Cancer CenterA targeted therapy resurrected by the Moon Shots Program at The University of Texas MD A
Study offers way to increase immune checkpoint inhibitor effectiveness in patients with MTAP-deleted cancers

Study offers way to increase immune checkpoint inhibitor effectiveness in patients with MTAP-deleted cancers

by Dana-Farber Cancer InstituteGraphical abstract. Credit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.09.005Loss of the "housekeeping" gene methylthioadenosine phosphorylas

Study offers way to increase immune checkpoint inhibitor effectiveness in patients with MTAP-deleted cancers

by Dana-Farber Cancer InstituteGraphical abstract. Credit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.09.005Loss of the "housekeeping" gene methylthioadenosine phosphorylas
Some cancer immunotherapy treatments may damage fertility

Some cancer immunotherapy treatments may damage fertility

by Monash UniversityCredit: Pixabay/CC0 Public DomainResearchers have discovered that some immunotherapy treatments used to treat cancer can cause fertility damage.It means these treatments could

Some cancer immunotherapy treatments may damage fertility

by Monash UniversityCredit: Pixabay/CC0 Public DomainResearchers have discovered that some immunotherapy treatments used to treat cancer can cause fertility damage.It means these treatments could
Experimental monoclonal antibodies can coax aggressive prostate and breast cancers into submission, finds research

Experimental monoclonal antibodies can coax aggressive prostate and breast cancers into submission, finds research

by Delthia Ricks , Medical XpressTherapeutic inhibition of VEGF binding to NRP2 activates anti-tumor immunity in a syngeneic model of prostate cancer that is resistant to aPD-L1 therapy. (A) Shown is

Experimental monoclonal antibodies can coax aggressive prostate and breast cancers into submission, finds research

by Delthia Ricks , Medical XpressTherapeutic inhibition of VEGF binding to NRP2 activates anti-tumor immunity in a syngeneic model of prostate cancer that is resistant to aPD-L1 therapy. (A) Shown is
Telisotuzumab vedotin shows durable response in some Asian patients with nonsquamous NSCLC

Telisotuzumab vedotin shows durable response in some Asian patients with nonsquamous NSCLC

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe c-Met-directed antibody-drug conjugate telisotuzumab vedotin demonstrated durable responses and an accepta

Telisotuzumab vedotin shows durable response in some Asian patients with nonsquamous NSCLC

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe c-Met-directed antibody-drug conjugate telisotuzumab vedotin demonstrated durable responses and an accepta
Metformin for rare skin cancer treatment: Research shows drug's unique ability to impact immune pathways

Metformin for rare skin cancer treatment: Research shows drug's unique ability to impact immune pathways

by Tsinghua University PressThis schematic illustrates the process of developing patient-derived skin tumor organoids from Dermatofibrosarcoma Protuberans (DFSP). The workflow includes organoid cultur

Metformin for rare skin cancer treatment: Research shows drug's unique ability to impact immune pathways

by Tsinghua University PressThis schematic illustrates the process of developing patient-derived skin tumor organoids from Dermatofibrosarcoma Protuberans (DFSP). The workflow includes organoid cultur